Cai K, Chen D, Wang G, Lu X, Zhang J, Tian Y
Department of General Surgery, Xiehe Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022.
J Tongji Med Univ. 2001;21(2):138-9. doi: 10.1007/BF02888078.
To investigate the correlation between the activity of kinases in the growth factor signal transduction pathway and the development of resistance of breast cancer to tamoxifen, reporter gene regulated by the regulating fragment of CCD1 was transfected into the MCF-7 cells, and the influence of tamoxifen on the reporter gene expression was examined under different conditions of TPA treatment. Our results showed that the reporter gene expression was inhibited by tamoxifen and promoted by TPA. Furthermore, tamoxifen exerts an agonist effect on the reporter gene expression when the cells was treated by TPA previously for 12 h. It is concluded that TPA could induce estrogen-like effect of tamoxifen on estrogen receptor positive breast cancer cells and it may be one of the mechanisms responsible for the development of tamoxifen resistance.
为研究生长因子信号转导途径中激酶活性与乳腺癌对他莫昔芬耐药性发展之间的相关性,将受CCD1调控片段调控的报告基因转染至MCF-7细胞中,并在不同TPA处理条件下检测他莫昔芬对报告基因表达的影响。我们的结果表明,他莫昔芬抑制报告基因表达,而TPA促进其表达。此外,当细胞预先用TPA处理12小时后,他莫昔芬对报告基因表达发挥激动剂作用。结论是,TPA可诱导他莫昔芬对雌激素受体阳性乳腺癌细胞产生类似雌激素的作用,这可能是他莫昔芬耐药性发展的机制之一。